Observational studies on glucocorticoids are harmful!
作者信息
Boers Maarten
机构信息
Department of Epidemiology and Biostatistics; Amsterdam Rheumatology & Immunology Center, VU University Medical Center, Amsterdam, The Netherlands.
出版信息
Lupus Sci Med. 2017 Apr 7;4(1):e000219. doi: 10.1136/lupus-2017-000219. eCollection 2017.
Abstract
摘要
相似文献
1
Observational studies on glucocorticoids are harmful!关于糖皮质激素的观察性研究是有害的！
Lupus Sci Med. 2017 Apr 7;4(1):e000219. doi: 10.1136/lupus-2017-000219. eCollection 2017.
2
Glucocorticoids in systemic lupus erythematosus.系统性红斑狼疮中的糖皮质激素。
Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S126-9. Epub 2011 Oct 22.
3
Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.在临床试验、长期观察性研究和临床护理中评估系统性红斑狼疮患者的指标。
Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-85-95. Epub 2014 Oct 30.
4
[Treatment of systemic lupus erythematosus: myths, certainties and doubts].[系统性红斑狼疮的治疗：误区、定论与疑问]
Med Clin (Barc). 2013 Dec 21;141(12):533-42. doi: 10.1016/j.medcli.2013.02.014. Epub 2013 Apr 23.
5
Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.糖皮质激素诱导的亮氨酸拉链（GILZ）抑制系统性红斑狼疮中的 B 细胞活化。
Ann Rheum Dis. 2016 Apr;75(4):739-47. doi: 10.1136/annrheumdis-2015-207744. Epub 2015 Nov 26.
6
Cardiac tamponade as an initial manifestation of systemic lupus erythematosus in a child.心脏压塞作为儿童系统性红斑狼疮的首发表现
Cardiol Young. 2014 Feb;24(1):172-4. doi: 10.1017/S1047951112001916. Epub 2013 Jan 25.
7
Immunosuppression in pregnant women with systemic lupus erythematosus.患有系统性红斑狼疮的孕妇的免疫抑制
Expert Rev Clin Immunol. 2015 May;11(5):549-52. doi: 10.1586/1744666X.2015.1033404. Epub 2015 Apr 5.
8
The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.狼疮影响追踪器对通过系统性红斑狼疮反应指数衡量的临床活动变化有反应。
Lupus. 2017 Apr;26(4):396-402. doi: 10.1177/0961203316667494. Epub 2016 Sep 28.
9
[Assessing the cardiovascular risk in patients with systemic lupus erythematosus].[评估系统性红斑狼疮患者的心血管风险]
Rev Med Interne. 2014 Nov;35(11):723-9. doi: 10.1016/j.revmed.2014.07.005. Epub 2014 Sep 16.
10
Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.抗 CD20 治疗难治性系统性红斑狼疮患者：52 例西班牙裔患者的纵向分析。
Lupus. 2010 Feb;19(2):213-9. doi: 10.1177/0961203309351541. Epub 2009 Dec 4.
引用本文的文献
1
Observational studies on glucocorticoid harm should always consider confounding by indication: comment on the article Katz et al.关于糖皮质激素危害的观察性研究应始终考虑适应证的混杂因素：对Katz等人文章的评论
ACR Open Rheumatol. 2025 Jun;7(6):e70023. doi: 10.1002/acr2.70023.
2
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial.在 GLORIA 随机双盲安慰剂对照试验中，接受 2 年低剂量附加泼尼松龙治疗的 65 岁以上活动性类风湿关节炎患者的体重和身体成分变化。
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2022-002905.
3
Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study. Reply.评论：关于“糖皮质激素对大型队列中骨量和脆性骨折具有矛盾性保护作用：一项横断面研究”的回复
Rheumatol Adv Pract. 2022 Feb 21;6(2):rkac011. doi: 10.1093/rap/rkac011. eCollection 2022.
4
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.降低大血管血管炎长期糖皮质激素治疗的毒性。
Curr Rheumatol Rep. 2020 Oct 12;22(12):85. doi: 10.1007/s11926-020-00961-0.
本文引用的文献
1
Independent association of glucocorticoids with damage accrual in SLE.糖皮质激素与系统性红斑狼疮中损伤累积的独立关联。
Lupus Sci Med. 2016 Nov 22;3(1):e000157. doi: 10.1136/lupus-2016-000157. eCollection 2016.
2
Studying the benefit/risk ratio of glucocorticoids in rheumatoid arthritis.研究糖皮质激素在类风湿关节炎中的获益/风险比。
J Rheumatol. 2007 Apr;34(4):661-3.
Zotero 插件